EHMT2 and glioblastoma: In vitro assays in established GBM lines show that EHMT2 is required for proliferation, migration, and invasion in a c-Myc dependent manner and that inhibition of EHMT2 leads to reduced global H3K9me2 and to increased apoptosis, autophagy markers, and differentiation in human primary GSCs (150, 151).